Clinical Trial Update: Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing vinorelbine plus gemcitabine versus capecitabine in pretreated metastatic breast cancer has completed; results are not report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)
• Xeloda (capecitabine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED